Roche Vitamins, Inc. v. United States
772 F.3d 728
Fed. Cir.2014Background
- Roche imported BetaTab, a mixture (20% beta‑carotene crystals plus antioxidants, gelatin, sucrose, corn starch) marketed as a source of provitamin A and usable as a colorant.
- Customs classified BetaTab under HTSUS 2106.90.97 (food preparations not elsewhere specified); Roche protested and sued in the Court of International Trade (CIT).
- At trial the CIT found BetaTab’s principal use was as a provitamin A source (especially for vitamin tablets) and that Roche’s manufacturing and added stabilizers did not change beta‑carotene’s character.
- Key legal issue: whether BetaTab qualifies under HTSUS heading 2936 (provitamins, unmixed) given Note 1(f) to Chapter 29 and Explanatory Note 29.36 permitting certain stabilizers so long as they don’t alter character or render product particularly suitable for a specific use.
- The CIT concluded BetaTab met heading 2936 and subheading 2936.10.00; the government appealed.
- The Federal Circuit reviewed legal questions de novo and factual findings for clear error, and affirmed the CIT’s classification of BetaTab as “Provitamins, unmixed.”
Issues
| Issue | Roche's Argument | Government's Argument | Held |
|---|---|---|---|
| Whether BetaTab is classifiable under HTSUS heading 2936 as a provitamin | BetaTab is a provitamin; added stabilizers are permitted and do not change its character | Processing/stabilizers render BetaTab particularly suitable for tablet use, excluding it from 2936 | Affirmed: BetaTab is classifiable under 2936; CIT factual findings not clearly erroneous |
| Whether Note 1(f)’s allowance for stabilizers is satisfied (quantity needed) | Stabilizers are used only in amounts necessary for preservation/transport | Government did not contest quantity on appeal | Not disputed on appeal; parties agreed stabilizer quantities were permissible |
| Whether processing/ additives altered character of beta‑carotene | Manufacturing does not change provitamin functionality or character | Processing makes product particularly suitable for specific use (tableting) | CIT finding that processing did not alter character affirmed (no clear error) |
| Whether added stabilizers rendered product particularly suitable for a specific use rather than general use | Stabilizers are conventional and used in other vitamin/beta‑carotene products; BetaTab remains suitable for general uses (foods, beverages, colorant) | High concentration/bioavailability makes BetaTab particularly suitable for tablets, excluding 2936 | Affirmed: stabilizers did not render BetaTab particularly suitable for a specific use; remains generally usable |
Key Cases Cited
- Roche Vitamins, Inc. v. United States, 750 F. Supp. 2d 1367 (Ct. Int'l Trade 2010) (CIT decision addressing summary judgment issues and stabilizer evidence)
- Roche Vitamins, Inc. v. United States, 922 F. Supp. 2d 1353 (Ct. Int'l Trade 2013) (trial‑level opinion reclassifying BetaTab under HTSUS 2936)
- Home Depot U.S.A., Inc. v. United States, 491 F.3d 1334 (Fed. Cir. 2007) (de novo review of HTSUS term interpretation)
- Degussa Corp. v. United States, 508 F.3d 1044 (Fed. Cir. 2007) (Chapter notes are integral part of HTSUS)
- Motorola, Inc. v. United States, 436 F.3d 1357 (Fed. Cir. 2006) (Explanatory Notes are persuasive guidance)
- Nat'l Advanced Sys. v. United States, 26 F.3d 1107 (Fed. Cir. 1994) (factual classification reviewed for clear error)
- Orlando Food Corp. v. United States, 140 F.3d 1437 (Fed. Cir. 1998) (GRIs govern HTSUS classification)